G.F. Samelis

503 total citations
23 papers, 372 citations indexed

About

G.F. Samelis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, G.F. Samelis has authored 23 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in G.F. Samelis's work include Pancreatic and Hepatic Oncology Research (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). G.F. Samelis is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). G.F. Samelis collaborates with scholars based in Greece, Cyprus and Netherlands. G.F. Samelis's co-authors include Konstantinos Ekmektzoglou, Theodoros Xanthos, Pavlos Papakostas, Dimosthenis Skarlos, Gerasimos Aravantinos, George Fountzilas, Gonzalo Rubio, J van Ark-Otte, Giuseppe Giaccone and Meletios Α. Dimopoulos and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

G.F. Samelis

23 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G.F. Samelis Greece	10	247	159	121	68	54	23	372
Masafumi Tanaka Japan	8	298 1.2×	118 0.7×	140 1.2×	10 0.1×	56 1.0×	31	421
Emir Charles Roach Türkiye	10	83 0.3×	164 1.0×	86 0.7×	85 1.3×	58 1.1×	17	364
M. Guaraldi Italy	14	332 1.3×	261 1.6×	182 1.5×	37 0.5×	91 1.7×	27	566
Masaki Wato Japan	11	100 0.4×	140 0.9×	179 1.5×	22 0.3×	20 0.4×	40	291
Robert Bachmann Germany	11	195 0.8×	99 0.6×	169 1.4×	30 0.4×	34 0.6×	36	424
Anne-Cécile Métivier France	10	67 0.3×	163 1.0×	105 0.9×	48 0.7×	45 0.8×	21	299
Brigitte Honhon Belgium	7	269 1.1×	133 0.8×	192 1.6×	26 0.4×	19 0.4×	12	363
Koujiro Nishida Japan	10	144 0.6×	172 1.1×	183 1.5×	11 0.2×	97 1.8×	15	395
Erjiang Tang China	10	177 0.7×	117 0.7×	55 0.5×	12 0.2×	58 1.1×	22	368
Mitsuru Yoshino Japan	9	109 0.4×	173 1.1×	51 0.4×	37 0.5×	64 1.2×	38	388

Countries citing papers authored by G.F. Samelis

Since Specialization

Citations

This map shows the geographic impact of G.F. Samelis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.F. Samelis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.F. Samelis more than expected).

Fields of papers citing papers by G.F. Samelis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.F. Samelis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.F. Samelis. The network helps show where G.F. Samelis may publish in the future.

Co-authorship network of co-authors of G.F. Samelis

This figure shows the co-authorship network connecting the top 25 collaborators of G.F. Samelis. A scholar is included among the top collaborators of G.F. Samelis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.F. Samelis. G.F. Samelis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kokkali, Stefania, I. Boukovinas, E. Samantas, et al.. (2022). A Multicenter, Prospective, Observational Study to Assess the Clinical Activity and Impact on Symptom Burden and Patients’ Quality of Life in Patients with Advanced Soft Tissue Sarcomas Treated with Trabectedin in a Real-World Setting in Greece. Cancers. 14(8). 1879–1879. 3 indexed citations

Karamouzis, Michalis V., Ilias Athanasiadis, G.F. Samelis, et al.. (2021). The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study. Cancers. 13(12). 2884–2884. 15 indexed citations

Ekmektzoglou, Konstantinos, P. Apostolopoulos, G.F. Samelis, & Georgios Alexandrakis. (2017). Gastroesophageal junction and gastroesophageal junction carcinoma : a short update.. PubMed. 79(4). 471–479. 1 indexed citations

Ekmektzoglou, Konstantinos, G.F. Samelis, Sophia N. Karagiannis, Georgios Zografos, & Theodoros Xanthos. (2012). Genomic instability in ulcerative colitis: a prerequisite for cancer in the inflammatory colon?. PubMed. 75(3). 293–9. 2 indexed citations

Samelis, G.F., et al.. (2011). The Continuation of Bevacizumab Following Disease Progression in Patients with Metastatic Colorectal Cancer Offers a Survival Benefit. Hepatogastroenterology. 58(112). 1968–71. 3 indexed citations

Samelis, G.F., et al.. (2011). Survival Benefit with the Combination of Docetaxel, Gemcitabine and Erlotinib in Advanced and/or Metastatic Pancreatic Cancer Patients. Hepatogastroenterology. 58(110-111). 1776–81. 1 indexed citations

Ekmektzoglou, Konstantinos, G.F. Samelis, & Theodoros Xanthos. (2008). Heart and tumors: location, metastasis, clinical manifestations, diagnostic approaches and therapeutic considerations. Journal of Cardiovascular Medicine. 9(8). 769–777. 72 indexed citations

Samelis, G.F., Konstantinos Ekmektzoglou, Theodoros Xanthos, & Georgios Zografos. (2008). Small-Cell Lung Cancer: An Unusual Therapeutic Approach with More than 10-year Overall Survival. Case Report and Review of the Literature. Tumori Journal. 94(4). 612–616. 1 indexed citations

Samelis, G.F., et al.. (2008). Survival benefit with erlotinib-based chemotherapy in unoperable recurrent and/or metastatic pancreatic cancer. Journal of Clinical Oncology. 26(15_suppl). 15622–15622. 2 indexed citations

10.

Samelis, G.F., Konstantinos Ekmektzoglou, & George Zografos. (2006). Gastrointestinal stromal tumours: Clinical overview, surgery and recent advances in imatinib mesylate therapy. European Journal of Surgical Oncology. 33(8). 942–950. 14 indexed citations

11.

Kalofonos, Haralabos P., Gerasimos Aravantinos, P. Kosmidis, et al.. (2005). Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study. Annals of Oncology. 16(6). 869–877. 62 indexed citations

12.

Xiros, Nikolaos I., Theofanis Economopoulos, G.F. Samelis, et al.. (2005). Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group. Annals of Oncology. 16(5). 773–779. 13 indexed citations

13.

Samelis, G.F., Haralabos P. Kalofonos, Dimosthenis Skarlos, et al.. (2005). The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: A Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group. Urology. 66(2). 382–385. 6 indexed citations

14.

Samelis, G.F., Dimosthenis Skarlos, Dimitrios Bafaloukos, et al.. (2003). The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group. Urology. 61(6). 1211–1215. 17 indexed citations

15.

Dimopoulos, Meletios Α., Haralabos P. Kalofonos, C. Nicolaides, et al.. (2002). Vinblastine and Interferon-Gamma Combination with and without 13-Cis Retinoic Acid for Patients with Advanced Renal Cell Carcinoma. Oncology. 63(2). 130–138. 5 indexed citations

16.

Papakostas, Pavlos, Ch. Kouroussis, N. Androulakis, et al.. (2001). First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study. European Journal of Cancer. 37(15). 1833–1838. 40 indexed citations

17.

Janinis, Jim, et al.. (2000). Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study. Annals of Oncology. 11(2). 163–167. 27 indexed citations

18.

Kouroussis, Ch., N. Androulakis, S. Kakolyris, et al.. (1999). Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial. Cancer Chemotherapy and Pharmacology. 43(3). 257–262. 35 indexed citations

19.

Ark-Otte, J van, et al.. (1998). Effects of tubulin-inhibiting agents in human lung and breast cancer cell lines with different multidrug resistance phenotypes.. Oncology Reports. 9 indexed citations

20.

Stathopoulos, G., et al.. (1997). Long term breast cancer treatment with tamoxifen and second primary tumors. European Journal of Cancer. 33. S150–S151. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact